B cells and antibodies in the defense against Mycobacterium tuberculosis infection

JM Achkar, J Chan, A Casadevall - Immunological reviews, 2015 - Wiley Online Library
Better understanding of the immunological components and their interactions necessary to
prevent or control Mycobacterium tuberculosis (Mtb) infection in humans is critical for …

Vaccines against invasive Salmonella disease: Current status and future directions

CA MacLennan, LB Martin, F Micoli - Human vaccines & …, 2014 - Taylor & Francis
Though primarily enteric pathogens, Salmonellae are responsible for a considerable yet
under-appreciated global burden of invasive disease. In South and South-East Asia, this …

Estimating typhoid incidence from community-based serosurveys: a multicohort study

K Aiemjoy, JC Seidman, S Saha, SJ Munira… - The Lancet …, 2022 - thelancet.com
Background The incidence of enteric fever, an invasive bacterial infection caused by
typhoidal Salmonellae (Salmonella enterica serovars Typhi and Paratyphi), is largely …

[HTML][HTML] Typhoid and paratyphoid fever: a call to action

MM Gibani, C Britto, AJ Pollard - Current opinion in infectious …, 2018 - journals.lww.com
The advent of new generation TCVs offers us a practical and affordable public-health tool
that–for the first time–can be integrated into routine childhood immunization programmes. In …

Salmonellosis: An Overview of Epidemiology, Pathogenesis, and Innovative Approaches to Mitigate the Antimicrobial Resistant Infections

B Lamichhane, AMM Mawad, M Saleh, WG Kelley… - Antibiotics, 2024 - mdpi.com
Salmonella is a major foodborne pathogen and a leading cause of gastroenteritis in humans
and animals. Salmonella is highly pathogenic and encompasses more than 2600 …

Live attenuated vaccines for invasive Salmonella infections

SM Tennant, MM Levine - Vaccine, 2015 - Elsevier
Salmonella enterica serovar Typhi produces significant morbidity and mortality worldwide
despite the fact that there are licensed Salmonella Typhi vaccines available. This is primarily …

Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model

HC Dobinson, MM Gibani, C Jones… - Clinical Infectious …, 2017 - academic.oup.com
Background. To expedite the evaluation of vaccines against paratyphoid fever, we aimed to
develop the first human challenge model of Salmonella enterica serovar Paratyphi A …

Recent advances in lipopolysaccharide-based glycoconjugate vaccines

H Zhu, CS Rollier, AJ Pollard - Expert Review of Vaccines, 2021 - Taylor & Francis
Introduction The public health burden caused by pathogenic Gram-negative bacteria is
increasingly prominent due to antimicrobial resistance. The surface carbohydrates are …

Estimating the burden of paratyphoid a in Asia and Africa

MB Arndt, EM Mosites, M Tian… - PLoS neglected …, 2014 - journals.plos.org
Despite the increasing availability of typhoid vaccine in many regions, global estimates of
mortality attributable to enteric fever appear stable. While both Salmonella enterica serovar …

Polysaccharide Vaccines: A Perspective on Non-Typhoidal Salmonella

SR Perera, AS Sokaribo, AP White - Polysaccharides, 2021 - mdpi.com
Polysaccharides are often the most abundant antigens found on the extracellular surfaces of
bacterial cells. These polysaccharides play key roles in interactions with the outside world …